| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2075 | 2017 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 303 | 2022 |
| The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm–volume 2 A Hatzakis, V Chulanov, AC Gadano, C Bergin, Z Ben‐Ari, J Mossong, ... Journal of viral hepatitis 22, 26-45, 2015 | 184 | 2015 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 163 | 2022 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2 V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ... Journal of viral hepatitis 22, 6-25, 2015 | 142 | 2015 |
| Imatinib-induced fatal acute liver failure E Ridruejo, R Cacchione, AG Villamil, S Marciano, AC Gadano, ... World journal of gastroenterology: WJG 13 (48), 6608, 2007 | 119 | 2007 |
| The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease N Mendez-Sanchez, M Arrese, A Gadano, CP Oliveira, E Fassio, JP Arab, ... The Lancet Gastroenterology & Hepatology 6 (1), 65-72, 2021 | 109 | 2021 |
| The liver in times of COVID-19: What hepatologists should know E Ridruejo, A Soza Annals of hepatology 19 (4), 353-358, 2020 | 109 | 2020 |
| Strategies to manage hepatitis C virus (HCV) infection disease burden–volume 2 E Gane, D Kershenobich, C Seguin‐Devaux, P Kristian, I Aho, O Dalgard, ... Journal of viral hepatitis 22, 46-73, 2015 | 91 | 2015 |
| Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study E Fassio, S Díaz, C Santa, ME Reig, YM Artola, AA de Mattos, C Míguez, ... Annals of hepatology 9 (1), 63-69, 2010 | 80 | 2010 |
| Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome C Efe, AV Kulkarni, BT Beretta‐Piccoli, B Magro, A Stättermayer, ... Hepatology 76 (6), 1576-1586, 2022 | 77 | 2022 |
| Treatment with direct‐acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma F Piñero, M Mendizabal, E Ridruejo, F Herz Wolff, B Ameigeiras, ... Liver International 39 (6), 1033-1043, 2019 | 77 | 2019 |
| Outcome of COVID‐19 in patients with autoimmune hepatitis: an international multicenter study C Efe, R Dhanasekaran, C Lammert, B Ebik, F Higuera‐de la Tijera, ... Hepatology 73 (6), 2099-2109, 2021 | 67 | 2021 |
| Disease progression in patients with hepatitis C virus infection treated with direct-acting antiviral agents M Mendizabal, F Piñero, E Ridruejo, FH Wolff, M Anders, V Reggiardo, ... Clinical Gastroenterology and Hepatology 18 (11), 2554-2563. e3, 2020 | 61 | 2020 |
| Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma N Méndez-Sánchez, E Ridruejo, AA de Mattos, NC Chávez-Tapia, ... Annals of Hepatology 13, S4-S40, 2014 | 57 | 2014 |
| Breath-ammonia testing of healthy subjects and patients with cirrhosis R Adrover, D Cocozzella, E Ridruejo, A Garcia, J Rome, JJ Podesta Digestive diseases and sciences 57, 189-195, 2012 | 54 | 2012 |
| Central hypothyroidism and hypophysitis during treatment of chronic hepatitis C with pegylated interferon alpha and ribavirin E Ridruejo, A Flor, OG Mando European journal of gastroenterology & hepatology 18 (6), 693-694, 2006 | 50 | 2006 |
| Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina F Piñero, J Pages, S Marciano, N Fernández, J Silva, M Anders, A Zerega, ... World journal of hepatology 10 (1), 41, 2018 | 49 | 2018 |
| Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission M Mendizabal, F Pinero, E Ridruejo, M Anders, MD Silveyra, A Torre, ... Annals of Hepatology 21, 100298, 2021 | 48 | 2021 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The Lancet Gastroenterology & Hepatology 8 (10), 879-907, 2023 | 46 | 2023 |
